Tibira Therapeutics is based out of South San Francisco. Regado Bioscience, Inc. develops biopharmaceutical therapies. The Company discovers and researches injectable anti-thrombotics, including anticoagulants and antiplatelet agents, for the treatment of acute coronary syndrome, percutaneous coronary intervention, and coronary artery bypass grafting.Whalewisdom has at least 173 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2014-02-25. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
TIBIRA THERAPEUTICS, INC.701 GATEWAY BLVD
SOUTH SAN FRANCISCO CA 94080
Business Phone: 650-741-6625
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS